Asparkam

Country of origin: Russia, AI CN Marbiopharm Russia, AI CN October Russia, AI CN Tomskkhimpharm Russia, Akrikhin HFC Russia, Antiviral Russia, Asfarma Russia, Belgorodvitamins Russia, Biomed Russia, Bioreactor Russia, Biosynthesis Russia, Biokhimik Russia, Bori

Pharm-Group: Drugs that regulate water-electrolyte balance

Manufacturers: AI CN Leksredstva (Russia), AI CN Marbiofarm (Russia), AI CN Oktyabr (Russia), AI CN Tomskkhimpharm (Russia), Akrikhin HFC (Russia), Antiviral (Russia), Asfarma (Russia), Belgorodvitamins (Russia), Biomed (Russia), Bioreactor (Russia), Biosynthesis (Russia), B

International name: Potassium and magnesium aspartate

Synonyms: Aspangin, Asparkam-Akos, Asparkam-UBF, Asparkam-Ferein, Potassium and magnesium asparaginate Berlin-Chemie, Panangin

Dosage forms: tablets, injection solution, 350 mg tablets

Ingredients: Potassium and magnesium aspartate.

Indications for use: Arrhythmias: caused by hypokalemia, intoxication with cardiac glycosides, ventricular extrasystole; circulatory failure, correction of hypokalemia when using loop diuretics.

Contraindications: Renal failure, hyperkalemia, AV block II-III degree.

Side effects: Nausea, dizziness, diarrhea, impaired intraventricular conduction, facial flushing, thirst, decreased blood pressure, hyporeflexia, respiratory depression, impaired neuromuscular transmission, arrhythmias.

Interaction: Reduces the effectiveness of cardiac glycosides. Potassium-sparing diuretics and ACE inhibitors increase the risk of hyperkalemia.

Overdose: Manifested by conduction disturbances, especially with previous pathology of the conduction system.

Special instructions: Restrictions on use: Hyperkalemia, hypermagnesemia, acute and chronic renal failure.

Literature: Encyclopedia of Medicines 2003.